In an Oct. 9 discussion about…
In an Oct. 9 discussion about innovation, resilience and the [...]
In an Oct. 9 discussion about innovation, resilience and the [...]
The stars have aligned for Bristol Myers Squibb and Orbital [...]
Shuttle Pharmaceuticals has rocketed into the AI-driven drug discovery space [...]
It’s still early in the season, but Evommune has become [...]
Regeneron has posted updated clinical data on DB-OTO, providing more [...]
Transparency is often a word pharma companies like to use, [...]
Two ex-Moderna leaders have hit a milestone in their new [...]
Expedition Therapeutics is gearing up for a phase 2 trek [...]
Ono Pharmaceutical’s EP4 antagonist hit the primary progression-free survival endpoint [...]
After axing a vast array of federal research projects and [...]